AIM IMMUNOTECH INC. Debt Securities, Available-for-sale, Unrealized Loss
AIM IMMUNOTECH INC. (AIM) reported Debt Securities, Available-for-sale, Unrealized Loss of $4.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2020-05-14
- AIM IMMUNOTECH INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2020-03-31 was $4.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|---|
| 2020-03-31 | $4.00K 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $3.00K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |